in vivo
in vitro
Safety & Toxicology
Pharmacokinetic & Pharmacodynamic
Board of Directors
Management
Company
R&D
Partners
Contact
Enquiries
News
December 2009:
vivo
Pharm wins $250,000 innovation grant.
February 2009:
Expansion of U.S. operations with the opening of a new office in Research Triangle Park, North Carolina.
December 2008:
vivo
Pharm is pleased to announce the development of a rat bile duct cannulation model.
October 2008:
vivo
Pharm is pleased to announce the development of PC3-M human prostate cancer and G361 human melanoma induced cachexia models.
September 2008:
vivo
Pharm proudly announces development of liver and lung metastases models.
